InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Enyedy Mark J, Chief Executive Officer. Officer active across 4 companies, notably ImmunoGen, Inc.. Cumulatively, 12 disclosures have been recorded. Activity tracked since 30 June 2021. The latest transaction was disclosed on 2 June 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Enyedy Mark J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
7,490 shares0Common StockSEC:0001628280-26-040914:0
946 shares@ US$135.04100.0% of flowCommon StockSEC:0001127602-25-016729:0
6,650 shares0Common StockSEC:0001048477-25-000070:0
4,720 shares0Common StockSEC:0001048477-24-000100:0
584,397 sharesCommon StockSEC:0001104659-24-014715:0
51,234 shares0Common StockSEC:0001415889-24-002871:0
2,180 shares0Common StockSEC:0001048477-23-000072:0
995,157 shares@ US$4.5598.4% of flowCommon StockSEC:0001415889-23-011881:0
5,241 shares@ US$4.050.5% of flowCommon StockSEC:0001415889-23-010830:0
2,921 sharesCommon StockSEC:0000899243-22-036305:0
3,342 shares@ US$3.8250.3% of flowCommon StockSEC:0001415889-22-007327:0
3,849 shares@ US$5.520.4% of flowCommon StockSEC:0001179110-21-007317:0
12 of 12 declarations
About Enyedy Mark J
Enyedy Mark J is Directeur Général and has 12 filings in total. In the 12 most recent filings we hold, the dominant transaction nature is Attribution, with total buy and sell amounts shown as EUR 0, over the period from 2021-07-02 to 2026-06-04.
